Skip to main navigation
  • Skip to content
  • Skip to primary sidebar
Back to the Corporate Site
Veloxis

Back to the Corporate Site

Investor Relations

IR Menu

  • News & Releases
  • Download Center
  • Corporate Governance
    • Governance Documents
    • Risk Management
    • Reporting Compliance
    • Violations and Concerns
    • Whistleblower Policy
    • Whistleblowing Guidelines
  • Financial Information
    • Outlook
  • General Meetings

Download Center

Download Center

Click here for Archived files

Governance Statement
Statutory Corporate Governance Report for 2018, cf. art. 107b of the Danish Financial Statements Act
Annual Reports
2018 Annual Report
Interim Reports
Q3 2019 Interim Report
Q2 2019 Interim Report
Q1 2019 Interim Report
Webcast
Q3 2019 Audiocast
Q2 2019 Audiocast
Q1 2019 Audiocast
Presentations
Investor Relations Presentation
2019 AGM Presentation

Latest News & Releases

Jun 22, 2020
Transplant Therapeutics Consortium Receives Acceptance of Letter-of-Intent for iBox Scoring System as a Reasonably Likely Surrogate Endpoint from the Biomarker Qualification Program
Feb 17, 2020
Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020

View All

© 2021 All rights reserved. Veloxis Pharmaceuticals Inc. ENV-18-090.0 06/18

info@veloxis.com | 1-844-VELOXIS (835-6947), Monday-Friday, 9AM-7PM ET

Sitemap | Contact | Privacy Policy | Disclaimer